Cancer drugs

Union Budget 2024: Significant boost for health sector with cancer drug exemptions

NEW DELHI: Finance Minister Nirmala Sitharaman unveiled the Union Budget 2024 on Tuesday where one of the most significant aspects for the health sector was exempting three cancer drugs have beenfrom custom duties, which will result in cost reduction of the drugs. The exempted cancer drugs include Trastuzumab Deruxtecan, Osimertinib, and Durvalumab, which are primarily […]